Shelcie Fabre

1.2k total citations
7 papers, 81 citations indexed

About

Shelcie Fabre is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Shelcie Fabre has authored 7 papers receiving a total of 81 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 2 papers in Infectious Diseases and 2 papers in Pharmacology. Recurrent topics in Shelcie Fabre's work include SARS-CoV-2 and COVID-19 Research (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and COVID-19 epidemiological studies (1 paper). Shelcie Fabre is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and COVID-19 epidemiological studies (1 paper). Shelcie Fabre collaborates with scholars based in United States and Venezuela. Shelcie Fabre's co-authors include Matthew M. Hernandez, Michael D. Nowak, Emilia Mia Sordillo, Kaijun Jiang, Daniel Stadlbauer, Florian Krammer, Kathryn Twyman, Jessica Tan, Meagan McMahon and Jeffrey S. Jhang and has published in prestigious journals such as Nature, American Journal of Clinical Pathology and Substance Abuse.

In The Last Decade

Shelcie Fabre

5 papers receiving 79 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shelcie Fabre United States	3	62	25	13	10	7	7	81
Mike Mannell United States	3	91 1.5×	27 1.1×	10 0.8×	5 0.5×	16 2.3×	4	122
Jacquelyn Turcinovic United States	6	107 1.7×	29 1.2×	14 1.1×	6 0.6×	19 2.7×	19	129
Floidy Wafawanaka United States	5	56 0.9×	37 1.5×	11 0.8×	10 1.0×	12 1.7×	7	85
Gina Cuomo-Dannenburg United Kingdom	6	64 1.0×	26 1.0×	21 1.6×	11 1.1×	5 0.7×	9	111
Ling Meng China	3	42 0.7×	18 0.7×	34 2.6×	7 0.7×	4 0.6×	6	75
Homoud S. Algarni Saudi Arabia	4	50 0.8×	19 0.8×	8 0.6×	5 0.5×	3 0.4×	4	60
Kelvin K. H. Kwan Hong Kong	3	114 1.8×	31 1.2×	14 1.1×	8 0.8×	32 4.6×	3	139
Gabriella Ruffino United Kingdom	4	94 1.5×	29 1.2×	19 1.5×	6 0.6×	39 5.6×	5	127
Ludovic Glady France	3	48 0.8×	8 0.3×	22 1.7×	9 0.9×	6 0.9×	6	76
Aniefiok John Udoakang Gambia	4	38 0.6×	16 0.6×	6 0.5×	3 0.3×	9 1.3×	5	73

Countries citing papers authored by Shelcie Fabre

Since Specialization

Citations

This map shows the geographic impact of Shelcie Fabre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shelcie Fabre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shelcie Fabre more than expected).

Fields of papers citing papers by Shelcie Fabre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shelcie Fabre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shelcie Fabre. The network helps show where Shelcie Fabre may publish in the future.

Co-authorship network of co-authors of Shelcie Fabre

This figure shows the co-authorship network connecting the top 25 collaborators of Shelcie Fabre. A scholar is included among the top collaborators of Shelcie Fabre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shelcie Fabre. Shelcie Fabre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Alburquerque, Bremy, Marilyn Chung, Shelcie Fabre, et al.. (2023). Clinical, microbiological and genomic characterization of Gram-negative bacteria with dual carbapenemases as identified by rapid molecular testing. JAC-Antimicrobial Resistance. 6(1). dlad137–dlad137. 2 indexed citations

2.

Fabre, Shelcie, Adriana van de Guchte, Lourdes A. Delgado‐Noguera, et al.. (2021). Catheter-related bloodstream infection due to biofilm-producing Capnocytophaga sputigena. IDCases. 25. e01231–e01231. 2 indexed citations

3.

Hernandez, Matthew M., et al.. (2021). Comparison of real-time RT-PCR and RT-PCR/MALDI-TOF methods for SARS-CoV-2 detection in saliva. American Journal of Clinical Pathology. 156(Supplement_1). S9–S9. 1 indexed citations

4.

Chang, Judy C., Nicole Paul, Shelcie Fabre, et al.. (2021). A Rapid-Cycle Assessment Strategy for Understanding the Opioid Overdose Epidemic in Local Communities. Substance Abuse. 42(4). 888–895. 3 indexed citations

5.

Stadlbauer, Daniel, Jessica Tan, Kaijun Jiang, et al.. (2020). Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City. Nature. 590(7844). 146–150. 72 indexed citations

6.

Fabre, Shelcie, et al.. (1989). Evaluation de la protection sérologique contre la peste bovine du cheptel bovin tchadien. Revue d’élevage et de médecine vétérinaire des pays tropicaux. 42(2). 163–167.

7.

Fabre, Shelcie, et al.. (1982). Hépatite cholestatique et cytolytique due à l'isaxonine.. Therapies. 37(6). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact